AR105005A1 - Derivados de pirrolotriazinona como inhibidores de pi3k - Google Patents
Derivados de pirrolotriazinona como inhibidores de pi3kInfo
- Publication number
- AR105005A1 AR105005A1 ARP160101778A ARP160101778A AR105005A1 AR 105005 A1 AR105005 A1 AR 105005A1 AR P160101778 A ARP160101778 A AR P160101778A AR P160101778 A ARP160101778 A AR P160101778A AR 105005 A1 AR105005 A1 AR 105005A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- branched
- linear
- hydrogen atom
- independently represents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen derivados de pirrolotriazinona; así como procedimientos para su preparación, composiciones farmacéuticas que los comprenden y su uso en terapia como inhibidores de fosfoinositida-3-quinasas (PI3Ks). Reivindicación 1: Un compuesto de fórmula (1), o una de sus sales farmacéuticamente aceptables, o N-óxido, o derivado marcado con isótopo, en donde, n representa un número entero seleccionado de 1 ó 2; X e Y representa cada uno independientemente un átomo de nitrógeno o grupo CR³; R¹ y R² representa cada uno independientemente un átomo de hidrógeno o un grupo alquilo C₁₋₄ lineal o ramificado; R³ representa un átomo de hidrógeno, un átomo de halógeno, un hidroxilo, un grupo alquilo C₁₋₄ lineal o ramificado, un grupo C₁₋₄ alcoxi o un grupo halógenoalquilo C₁₋₄; Z representa un grupo -CH((CH₂)₀₋₁-NRᵃRᵇ)-, un grupo -NH- o un grupo -N(alquilo C₁₋₃)-; Rᵃ y Rᵇ representa cada uno independientemente un átomo de hidrógeno o un grupo alquilo C₁₋₄ lineal o ramificado; o Rᵃ y Rᵇ junto con el átomo de nitrógeno al que están unidos forman un grupo heterociclilo de 3 a 7 miembros, monocíclico, que contiene opcionalmente al menos un heteroátomo adicional seleccionado de O, S y N.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15382317 | 2015-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR105005A1 true AR105005A1 (es) | 2017-08-30 |
Family
ID=53496611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160101778A AR105005A1 (es) | 2015-06-16 | 2016-06-15 | Derivados de pirrolotriazinona como inhibidores de pi3k |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR105005A1 (es) |
TW (1) | TW201710270A (es) |
WO (1) | WO2016202800A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112028892B (zh) * | 2020-07-29 | 2022-12-16 | 天津全和诚科技有限责任公司 | 4-氨基-吡咯并三嗪衍生物在制备抗肺纤维化制剂中的应用 |
CN112920203A (zh) * | 2021-01-26 | 2021-06-08 | 浙江永太科技股份有限公司 | 一种瑞德西韦有关物质及其制备方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT7920688V0 (it) | 1979-02-05 | 1979-02-05 | Chiesi Paolo Parma | Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore. |
CY1492A (en) | 1981-07-08 | 1990-02-16 | Draco Ab | Powder inhalator |
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FI69963C (fi) | 1984-10-04 | 1986-09-12 | Orion Yhtymae Oy | Doseringsanordning |
DE3927170A1 (de) | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
IT1237118B (it) | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
DE4027391A1 (de) | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgeraet |
DE69132850T2 (de) | 1990-09-26 | 2002-05-29 | Pharmachemie B.V., Haarlem | Wirbelkammer-Pulverinhalator |
GB9026025D0 (en) | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
DE4239402A1 (de) | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
AU683036B2 (en) | 1992-12-18 | 1997-10-30 | Merck Sharp & Dohme Corp. | Inhaler for powdered medications |
PL182198B1 (en) | 1995-06-21 | 2001-11-30 | Asta Medica Ag | Pharmaceutic powder holding container with integrated measuring device and powdered |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
CN1997418B (zh) | 2004-07-16 | 2010-08-11 | 奥米罗有限公司 | 用于粉状药物给药的吸入器,以及用于与该吸入器一起使用的药粉筒系统 |
ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
PE20150637A1 (es) | 2012-10-16 | 2015-05-08 | Almirall Sa | Derivados de pirrolotriazinona como inhibidores de pi3k |
-
2016
- 2016-06-14 WO PCT/EP2016/063635 patent/WO2016202800A1/en active Application Filing
- 2016-06-15 TW TW105118755A patent/TW201710270A/zh unknown
- 2016-06-15 AR ARP160101778A patent/AR105005A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2016202800A1 (en) | 2016-12-22 |
TW201710270A (zh) | 2017-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124726T1 (el) | Παραγωγα κιναζολινης που χρησιμοποιουνται για την αντιμετωπιση του hiv | |
CY1121418T1 (el) | Παρεμποδιστες ιου ηπατιτιδας c | |
CY1122695T1 (el) | Αλας toy omecamtiv mecarbil και διαδικασια για την παρασκευη αλατος | |
CY1121413T1 (el) | Διυδροπυρρολοπυριδινης αναστολεις ror-γαμμα | |
NI201700020A (es) | Compuestos de aminopirimidinilo como inhibidores de jak | |
UY35485A (es) | Compuestos heterocíclicos y usos de los mismos | |
CL2016000468A1 (es) | Conjugados anti-dll3 (ligando3 tipo delta) manipulados y métodos de uso. | |
UY36285A (es) | Compuestos que inhiben la proteína mcl-1 | |
CO2018004857A2 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
UY35586A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
NI201200191A (es) | Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica | |
UY35663A (es) | Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos | |
ECSP17007208A (es) | Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble | |
AR081628A1 (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
AR093036A1 (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
BR112016012146A2 (pt) | Compostos derivados de aminopiridina como inibidores quinase da família tam, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos | |
AR088828A1 (es) | DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3 | |
CO2019006220A2 (es) | Compuestos de pirazolopirimidina y métodos de uso de los mismos | |
UY36124A (es) | Derivados de carboxamida | |
AR098723A1 (es) | Derivados de pirazolopirimidin-2-ilo como inhibidores de jak | |
UY35332A (es) | Derivados de pirrolotriazina como inhibidores de pi3k | |
MX2015013224A (es) | Inhibidores macrociclicos y biciclicos del virus de la hepatitis c. | |
UY35087A (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
CY1123744T1 (el) | Παραγωγα πυριδινυλιου, φαρμακευτικες συνθεσεις και χρησεις αυτων ως αναστολεων aoc3 | |
CL2020001277A1 (es) | Derivados de piridinona y su uso como inhibidores selectivos de alk-2. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |